Viewing Study NCT02326168


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2026-01-23 @ 2:56 PM
Study NCT ID: NCT02326168
Status: COMPLETED
Last Update Posted: 2017-01-25
First Post: 2014-12-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer
Sponsor: The University of Texas Health Science Center at San Antonio
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module